Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

cbdMD Releases ‘Premium Relieve’ with Lidocaine, Expanding Upon Diverse Topical Offerings Featuring Superior Broad Spectrum CBD Formula


With ‘Premium Relieve’, cbdMD is proud to now offer an expanded topicals line that is well-rounded and balanced for health-minded individuals and anyone seeking to enhance their personal wellness.

With ‘Premium Relieve’, cbdMD is proud to now offer an expanded topicals line that is well-rounded and balanced for health-minded individuals and anyone seeking to enhance their personal wellness.

At cbdMD, we’re revolutionizing the topical market by introducing innovative products that continue to lead in each category.

cbdMD, Inc. (NYSE American: YCBD, YCBD PR A) (the “Company”), one of the leading, and most highly trusted and recognized cannabidiol (CBD) brands, announced today an expansion of its topical product line with the launch of ‘Premium Relieve’, a product that combines the pain-fighting power of Lidocaine with Superior Broad Spectrum CBD extracts – leading to total wellness in one unique topical formula.

Available in a roll-on applicator or spray, Premium Relieve combines the proven powers of Lidocaine (4%) with cbdMD’s Superior Broad Spectrum formula, providing temporary relief from minor muscle aches and pains.

Premium Relieve joins a diverse offering of topical products featuring high profile over-the-counter (OTC) pain relief ingredients fused with cbdMD’s unique hemp extract blend, including:

Premium Freeze Pain Relieving Formula (‘2020 Product of the Year’ Winner: CBD Topical) – cbdMD’s award-winning Freeze gel offers the proven pain-relief properties of menthol, blended with the power of domestically sourced CBD, to provide temporary pain relief while working to ease aching muscles and joints.

Premium Recover Pain Relieving Formula – cbdMD’s Recover combines pain-relieving agent Histamine Dihydrochloride (0.05%) with the whole-body benefits of cbdMD’s Superior Broad Spectrum CBD formula into a unique, richly moisturizing cream that’s great for temporary relief of pain and muscle aches, without any of the smell.

cbdMD’s release of Premium Relieve marks an advancement in the topical market as it is one of the few CBD topicals available in aerosol spray form, utilizing a unique Bag-on-Valve Technology that allows for spraying at any angle and covering difficult-to-reach areas. In addition, Premium Relieve contains the most abundant CBD content of any Lidocaine-infused topical currently on the market.

“Topicals have never been more popular for consumers, with more and more products adding CBD to their formulas these days,” said Ken Cohn, Chief Marketing Officer at cbdMD. “At cbdMD, we’re revolutionizing the topical market by introducing innovative products that continue to lead in each category. With ‘Premium Relieve’, we are proud to now offer an expanded topicals line that is well-rounded and balanced, with broad appeal to not only health-minded individuals, but anyone seeking to enhance their personal wellness.”

To learn more about cbdMD and their comprehensive line of U.S. grown, non-THC1 CBD oil products, please visit: http://www.cbdmd.com.

About cbdMD, Inc.

cbdMD, Inc. is one of the leading, most highly trusted, and most recognized cannabidiol (CBD) brands, whose current products include CBD tinctures, CBD capsules, CBD gummies, CBD topicals, CBD bath bombs and CBD pet products. cbdMD is also a proud partner of Bellator MMA and Life Time, Inc., and has one of the largest rosters of professional sports athletes who are part of “Team cbdMD.” To learn more about cbdMD and our comprehensive line of over 100 SKUs of U.S. produced, Non-THC[1] CBD products, please visit http://www.cbdMD.com, follow cbdMD on Instagram and Facebook, or visit one of the 6,000 retail outlets that carry cbdMD products.

Forward-Looking Statements

This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as ”should,” ”may,” ”intends,” ”anticipates,” ”believes,” ”estimates,” ”projects,” ”forecasts,” ”expects,” ”plans,” and ”proposes.” These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including, without limitation, statements made with respect to the expansion of the consumer market for CBD products and our ability to increase our market share, our limited operating history, our ability to expand our business and significantly increase our revenues, our ability to effectively leverage our brand partnerships and sponsorships, our ability to effectively compete in our market, our ability to achieve our net sales guidance, and our ability to report profitable operations in the future. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading “Risk Factors” in cbdMD, Inc.’s Annual Report on Form 10-K for the fiscal year ended September 30, 2019 as filed with the Securities and Exchange Commission (the “SEC”) and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.

1 Non-THC is defined as below the level of detection using validated scientific analytical tools.

Contact:

PR:

cbdMD, Inc.

Lauren Greene

Communications Specialist

Lauren.Greene@cbdMD.com

(843) 743-9999

Investors:

cbdMD, Inc.

John Weston

Director of Investor Relations

John.Weston@cbdMD.com

(704) 249-9515

Share article on social media or email:



ReST® Releases an Always-On Sleep Quality Monitor™


ReST NightVision

Using ReST’s patented AI Inside™ smart bed technology, NightVision collects and reports sleep data derived from real-time respiration and body movement.

ReST, the leader in sleep technology, has released NightVision™, a revolutionary Sleep Quality Monitor™. Using ReST’s patented AI Inside™ smart bed technology, NightVision™ collects and reports sleep data derived from real-time respiration and body movement. The NightVision™ app is available to new and existing ReST Bed™ users as part of the ReST Bed™ application.

NightVision™ is superior to other sleep tracking solutions because it measures respiration rate and body movement directly. This data is used to generate statistics on sleep stages and cycles, respiratory rate with timeline, wake after sleep onset, restless movements, body position percentage during the night, and total sleep time. NightVision’s™ other advantages are: unlike a wearable, nothing has to be attached to the user’s body; NightVision™ is always-on; NightVision™ does not require any training; no applications have to be running on the user’s device; and because NightVision™ uses the patented pressure sensing technology that is already part of a ReST Bed™, there is no additional cost to consumers.

Respiratory Rate Variability (RRV) is critical to ensuring the accurate measure of sleep quality and sleep stages. According to a report by The Physiological Society, capturing RRV is challenging because doing so requires the analysis of respiratory signals over a period of several hours . NightVision’s™ ability to directly detect respiration rate and body movements in real time provides users with quality sleep data and a complete respiratory timeline

“We believe in using technology to provide consumers a good night’s sleep,” says Lloyd Sommers, ReST general manager. “The ReST Bed’s™ pressure sensing technology set the standard for what a smart bed is. NightVision™, our new Sleep Quality Monitor™, will likewise change what consumers expect from sleep tracking.”

NightVision™ requires a brief one-time on-boarding process and data can be accessed remotely when not at home. HIPAA compliant and stored on the Azure (Microsoft) cloud, NightVision™ can be turned off at any time. NightVision™ does not make any medical claims and is not a substitute for a medical professional.

For more information about ReST and NightVision™, visit http://www.restperformance.com.

About ReST

ReST’s mission is to provide the ultimate sleeping experience. ReST is the only company with an integrated technology solution that not only monitors movement in real-time but automatically responds to those unique and personal changes. Our main product is the ReST Bed™: the only truly smart bed. The ReST Bed™ incorporates our patented smart fabric, which senses changes in pressure and interacts with the mattress in order to automatically respond to the sleeper’s comfort and support needs throughout the night. Above all, ReST Beds™ help sleep better so that they can live healthier and more productive lives. For more information on ReST, visit http://www.restperformance.com

Share article on social media or email:

New Lifestyle Company HARMONY783 Launches Innovative Grounding Footwear


News Image

…we created HARMONY783 to help make ‘earthing’ and ‘grounding’ as accessible as possible to mainstream populations. What better way to do this than by innovating timeless, stylish, comfortable and biomechanically correct shoes that fit all lifestyles and enable people to get grounded everyday.

Grounding footwear and lifestyle company, HARMONY783, announced today the launch of its flagship product — stylish women’s and men’s grounding footwear designed and engineered to reconnect people with the Earth’s natural energy, enabling them to optimize their health simply by wearing shoes. Co-founded by Pamela Bard and Sharon Whiteley, the company was birthed in Evergreen, CO and has executive offices in Tucson, AZ.

The term ‘grounding’, also known as ‘earthing,’ is scientifically proven to be beneficial to one’s well-being. The act of grounding means one is connecting to the earth’s electromagnetic field, which is filled with balancing electrons. Like plugging into a giant battery to get recharged, this practice replenishes the body with beneficial energy from the earth. Over 21 published scientific studies, numerous books, and three full-feature documentary films substantiate these findings. HARMONY783 has also conducted their own scientifically protocoled research to prove the efficacy of grounding through footwear.

Modern “urbanized” life and synthetic-soled shoes (the majority on the market) insulate humans from being grounded. HARMONY783’s shoes are a solution enabling people to get grounded during their daily lives and in a range of activities; the same benefits one can derive by walking barefoot on the ground. Being grounded normalizes overall health, and is also proven to enhance one’s immune system, especially important during these times.

“Grounding is what brought Pam and I together,” says Sharon Whiteley, CEO. “It changed our lives, literally and figuratively, and we created HARMONY783 to help make ‘earthing’ and ‘grounding’ as accessible as possible to mainstream populations. What better way to do this than by innovating timeless, stylish, comfortable and biomechanically correct shoes that fit all lifestyles and enable people to get grounded everyday”.

HARMONY783’s trend-on shoe collection fits into contemporary life seamlessly. Styles range from everyday Loafers, great for lounging around at home or when out and about, to sneakerinspired Walkers and versatile Joggers. All shoes feature fully conductive carbon and rubber outsoles that are bio-mechanically engineered for comfort and support. Their patent pending technology, called Groundworks®, features 99.99% pure silver material through the midsoles connecting up through microfiber footbeds which are stitched with ionically plated pure silver thread. Silver is highly conductive and enables the flow of the earth’s natural energy up into one’s body. HARMONY783 also offers grounding flip flops year-round which utilize their proprietary carbon and rubber plug technology.

Committed to both human and environmental sustainability, HARMONY783 features BLOOM bio-friendly algae-based EVA in the midsoles of their athleisure sneaker-styled Walkers and everyday Joggers. In addition, they utilize recyclable and minimal packaging at every opportunity and have protocols in place that help support the planet and the earth – which is HARMONY783’s main product ingredient.

Learn more at: http://www.harmony783.com

About HARMONY783:

HARMONY783 is an innovative lifestyle company created in response to the desires of today’s health conscious consumers who want to optimize their health, look good, and feel even better. Their flagship product line features classic and timeless grounding footwear for both women and men.

Share article on social media or email:

Decode Health Expands Strategic Advisory Board


“Adding Cynthia Kilroy and Dr. Frank Cockerill to our Strategic Advisory Board is important to the growth and success of our company,” said Chase Spurlock, PhD, founder and CEO of Decode Health.

Chase Spurlock, PhD, founder and CEO of Decode Health, announced the addition of two members to the company’s Strategic Advisory Board. New members Cynthia Kilroy and Dr. Franklin Cockerill expand the depth and breadth of industries represented on the board, joining the eight members announced earlier in 2020 who provide guidance on technology development, partnership opportunities, and ongoing business strategies.

Decode Health’s predictive analytics solutions are used by health care providers, payers, public health officials, and policymakers to identify risk, inform care, and improve outcomes for the populations they serve. The company combines multiple data sources, including public health information, clinical data, healthcare claims, geographically targeted social determinants of health information, real-time patient survey results, and other enrichment data, to deliver actionable insights. Decode Health’s insights are extensible to multiple healthcare fronts and conditions, including chronic disease, COVID-19 spread, and now the emerging need to monitor those whose COVID-19 infection may be leading to long-term, chronic conditions.

“Adding Cynthia Kilroy and Dr. Cockerill to our Strategic Advisory Board is important to the growth and success of our company,” said Spurlock. “We’re delighted to have them join the other accomplished advisory board members who are helping us negotiate this transformational period in healthcare and our own company’s evolution.” 

Franklin R. Cockerill, III, MD, FACP, FACCP, FAAM, FIDSA is currently CEO, FRC3Lab, LLC, a private consulting company for clinical diagnostic testing. Before launching his consulting company, he served as CEO, Chief Medical Officer, and board director for Analyte Health. Before joining Analyte Health, Dr. Cockerill was the Chair of the Department of Laboratory Medicine and Pathology, Mayo Clinic, and President and CEO of Mayo Medical Laboratories (MML). While at Mayo, he also carried a named professorship, the Ann and Leo Markin Professor of Medicine and Microbiology at Mayo Clinic Alix School of Medicine. Dr. Cockerill is board certified in internal medicine and infectious diseases and clinical microbiology. He practiced internal medicine and in infectious disease for over a decade before shifting his focus to clinical microbiology. 

Cynthia Kilroy, MBA, is the founder of a healthcare consulting practice where she brings a unique form of creative advisory services to healthcare leaders. Before starting her consultancy, she was Vice President of Strategy and Acquisitions, Healthcare for Cognizant Technology Solutions, where she led industry strategy, deal flow, mergers and acquisitions, market development, strategic sales, and executive engagement for new value propositions and emerging technologies across Cognizant’s $3 billion healthcare portfolio. Kilroy was previously Senior Vice President of Provider Strategy for Optum Accountable Care Solutions, and she has a deep history in top-tier consulting firms and hospital systems and health plans, including Huron Consulting Group, Andersen Consulting, KPMG, El Camino Hospital, U.S. Healthcare (Aetna), Mercy Health Plan, and McKesson. She received her MBA from Duke University, Fuqua School of Business with a Health Sector Management certification. She is a frequent speaker and writer on value-based care transformation, digital platforms, and healthcare trends.

“Adding these members, with their unique experiences, adds to the breadth and depth of advising that Decode Health has at its disposal,” Spurlock added. “Dr. Cockerill’s expertise in laboratory services and diagnostic innovation will be invaluable as we advance our COVID-19 surveillance efforts and strengthen our chronic disease monitoring capabilities. Cynthia’s knowledge across all facets of the healthcare system, especially within the emerging payer-provider partnerships arena and the use of technology to deliver personalized care, will support our expanding value proposition. With their support and guidance, along with that from all of our advisors, we are well-positioned to understand and take advantage of the growth opportunities for our organization.”

About Decode Health:

http://www.decodehealth.ai

Decode Health is a Nashville-based predictive analytics company deploying AI and machine learning to improve outcomes and create cost savings on two critical healthcare fronts: COVID-19 mitigation and Chronic Disease management. Decode Health’s predictive analytics derived from multiple data sources including public health information, healthcare claims, clinical information, and proprietary, geographically relevant social determinants of health, provide actionable insights early, enabling proactive care, better outcomes, and significant cost savings.

Share article on social media or email:

SPH Analytics Ranked by Modern Healthcare as Top Patient Experience Measurement Vendor in the Health Plan/Payer Market for the Fourth Consecutive Year


SPH is the top patient experience measurement vendor in the payer space

SPH is the top patient experience measurement vendor in the payer space

Our large datasets built from our extensive footprint in the health care market over thirty-five years are the foundation for our comparative benchmarks and predictive analytics…

SPH Analytics (SPH), the leader in health plan member experience, announced today it has been ranked, for the fourth year in a row, as the top vendor in the Insurer/Managed Care Plan category of Modern Healthcare’s list of largest patient satisfaction measurement firms.

The rankings, published in the magazine’s October 26, 2020 issue, are based on reported client counts for 2019 performance. SPH clients include most of the nation’s health plans, as well as hospitals, health systems, ambulatory surgery centers, physician practices, Accountable Care Organizations, home health and hospice agencies, dialysis centers, and pharmacy benefit managers.

“Year after year, SPH continues making strides in measuring, analyzing and improving health care consumer experience and engagement,” said Amy Amick, CEO and President of SPH Analytics. “Our large datasets built from our extensive footprint in the health care market over thirty-five years are the foundation for our comparative benchmarks and predictive analytics that leading health plans and providers rely on to drive healthy, cost-effective behaviors, while improving customer experience and loyalty.”

SPH Analytics currently serves over 71% of all U.S. health plans, representing 98% of all health plan enrollees, and 60,000+ healthcare providers. As the only vendor certified to conduct all CMS- and NCQA-mandated surveys, SPH provides its clients with advanced analytics and benchmarking, a wide-ranging set of regulatory and insight surveys, custom market research, smart, omnichannel patient/member outreach and engagement capabilities, and full-service population health management.

Modern Healthcare is number one in readership among healthcare executives and a leading source of healthcare business and policy news, research, and information.

About SPH Analytics

SPH Analytics (SPH), a leader in healthcare analytics and population health management, empowers clients to analyze and interpret their clinical, financial, and consumer experience data to maximize their performance. SPH’s Population Care™, Population Value™, and Population Engage™ solutions are built on the innovative Nexus™ Platform, providing insights and impact to integrated health networks, ACOs, hospitals, ambulatory care providers, physician groups, and health plans. SPH’s quality measure dashboards, financial risk measurement, healthcare survey and call center solutions, and consulting services empower clients to meet the Triple Aim by improving population health, reducing overall cost of care, and improving the patient experience.

SPH Analytics is a recognized leader in the industry, earning accolades as a top ranked population health vendor by KLAS, ranked the number one analytics firm out of the top 50 disruptive health IT companies by Black Book Research, and ranked number one in MACRA and MIPS Support Technology for Value-Based Care by Black Book Research. SPH Analytics has been providing insights to clients for more than 35 years and serves clients in all 50 states. Corporate headquarters are in metro Atlanta. SPH Analytics is a portfolio company of the $3 billion Symphony Technology Group. For more information, call 1-866-460-5681 or visit SPHAnalytics.com.

Share article on social media or email:

Interbit Data to Hold Webinar: ‘From Attack to Recovery: Your Cybersecurity Battle Plan’


News Image

Interbit Data, a leading technology company providing care teams with on-demand access to crucial patient data, will host a webinar on Thursday, Dec. 3 discussing how hospitals should respond in the wake of a crippling cyberattack.

The webinar is titled, “From Attack to Recovery: Your Cybersecurity Battle Plan” and will be led by Interbit Data President and CEO Arthur Young. It’s the second Interbit Data webinar on the topic of hospital cyberattacks, and it follows a recent alert from the FBI, the Cybersecurity and Infrastructure Security Agency, and the U.S. Department of Health and Human Services warning of “an increased and imminent cybercrime threat to U.S. hospitals and healthcare providers.”

Young, an entrepreneur with an extensive background in healthcare and technology, believes that systems restoration should be only part of a hospital’s response plan and that people, not technology, are ultimately the most important factor in cybersecurity. As such, he will outline what needs to go into a hospital’s disaster response plan and post-attack communications plan.

“You want to create a playbook so that people know what to do and they’re not left alone — especially because communication will be compromised in all these scenarios,” said Arthur Young, President and CEO of Interbit Data. “You’re not trying to create a new solution, you’re looking to get as close to normal as possible in a remarkable situation.”

Hospital and health system leaders, healthcare IT vendors, industry consultants and analysts, and members of the news media are invited to attend the webinar.

Webinar: From Attack to Recovery: Your Cybersecurity Battle Plan

Date: Thursday, Dec. 3, 2020

Time: 1-1:45 p.m. ET

Register here

About Interbit Data

Interbit Data is an industry leader in data accessibility for hospitals and health systems. Our software solutions ensure secure, reliable access to patient information anytime, anywhere – including at offsite locations, during system downtimes, and even during cyberattacks. With more than 23 years in business and more than 700 customers across North America, we are experts at data access and report distribution, empowering you to improve efficiency, streamline workflows, provide optimal patient service and high-quality care, all while meeting federal patient privacy and access requirements. Discover more at interbitdata.com.

Share article on social media or email:

National Pediatric Cancer Foundation Hosts Annual “Fashion Funds the Cure” In Support of Childhood Cancer Research and Treatment


A childhood cancer patient and her matching role model walk the runway at last year’s event. (Image courtesy of National Pediatric Cancer Foundation.)

The National Pediatric Cancer Foundation (NPCF) will host its annual Fashion Funds the Cure fundraising event, presented by Mercedes-Benz, on Friday, November 13 at 6:00pm EST. The leading national nonprofit organization, which funds groundbreaking research for childhood cancer treatment, hosts the event for childhood cancer survivors and their families across the nation. This year, in light of COVID restrictions, the NPCF has worked tirelessly to recreate the event, closely following all safety guidelines.

The highlight of the event is a fashion show, where childhood cancer survivors take to the runway dressed as their future career aspirations. This year, with safety and wellness as the highest concern, the show will incorporate an innovative combination of live and virtual participants. Childhood cancer survivors, who are especially vulnerable to illness, were asked to send in videos to participate remotely. These videos will match live role models, who will walk the stage in person to honor the children. Behind the scenes, the role models will be protected as well, with a carefully planned show and highly restricted access to their space.

Nearly 42 kids nationwide will be participating with a pre-recorded video, each walking their own virtual “runway” in a special feature. Further, the event will be livestreamed via social media and YouTube. Supporters across the nation are invited to follow the NPCF Instagram, Facebook, Twitter or YouTube, where they can tune in and join the fun on Friday.

Supporters at the event itself can choose between several different event experiences in different areas, each of which will be socially distanced in its own way. As part of a plan approved by the county, all guests will complete a waiver, wear masks for the duration of the event, and remain their designated event area without mixing with other parties. While enjoying the fashion show, guests will either be safely enjoying hors d’oeuvres, learning expert cooking tips, or cheering from a socially-distanced audience. Top-level sponsors will even have access to a private luxury suite, where they can watch the show while enjoying light bites and cocktails.

The uplifting, high-energy show will feature professional models and local business leaders along with the videos of children battling cancer across the nation. The event also features both a live and silent auction, accessible to all attendees regardless of their location. Fashion Funds the Cure presented by Mercedes-Benz provides the unique opportunity to both raise critical funds for research, and celebrate what has already been accomplished.

“We are pleased to bring back this year our annual Fashion Funds the Cure presented by Mercedes-Benz,” said David Frazer, CEO of the NPCF. “The event is a bright moment for these kids and their families, who have been looking forward to it all year. It’s also a crucial moment to help raise awareness and funding for lifesaving research and treatment of childhood cancer. This has been an unimaginably challenging year to many, especially for young cancer patients and their health professionals who needed to take extra precautions to ensure their safety. We greatly appreciate our community’s support and continue to rely on it in fulfilling our mission of fast-tracking less toxic, more targeted treatment.”

“I am honored to be the National Pediatric Cancer Foundation’s International Youth Chair because of the amazing, tireless, inspiring work that they are doing to find a cure for pediatric cancer,” said Kathy Ireland, who will be sending a personalized message in support of the event. “Every day 43 precious children and their families in the United States have their lives turned upside down with the news that their child has cancer. Just imagine the joy that they will be feeling when they can watch their child walk down the runway, smiling from ear to ear. Imagine how wonderful it will feel when every child and their family can learn that they are cancer-free. Please, join us in our efforts to offer all young people that beautiful promise.”

Since their inception in 1991, the NPCF has supported more than $25 million in pediatric cancer research, and their groundbreaking Sunshine Club has united 26 leading hospitals and research institutions across the country to identify promising new treatments. Tickets for Fashion Funds the Cure presented by Mercedes-Benz are $175 per person and can be purchased online at Nationalpcf.org/fashiontampa or by phone (813) 269-0955.

About National Pediatric Cancer Foundation

The National Pediatric Cancer Foundation is a nonprofit organization dedicated to funding research to eliminate childhood cancer through the Sunshine Project, the Foundation’s collaborative research initiative. By partnering with doctors and researchers from the country’s top institutions, the Sunshine Project is fast-tracking the development of new drugs and therapies that will ultimately lead to the cure of childhood cancers. The NPCF has received a perfect 100% score for financial health and transparency and is recognized as the top-rated cancer charity in the U.S. by Charity Navigator. For more information, visit http://www.NationalPCF.org or connect via Facebook, Twitter or Instagram.

Share article on social media or email:

44% of Healthcare Consumers Prefer to Receive a Combination of Both In-Person and Virtual Care Post-COVID-19


News Image

“Blended care delivery models consisting of both in-person and virtual care are playing a crucial role in improving patient experience and, more importantly, outcomes,” said Puneet Maheshwari, co-founder and CEO of DocASAP.

DocASAP, the industry’s most advanced patient access and engagement platform for health systems, health plans and physician groups, today announced the results of its second annual “State of Patient Access and Engagement” 2020 survey. The survey, conducted by OnePoll and commissioned by DocASAP, reveals how healthcare consumers are adjusting to the new normal, including the lasting impact of COVID-19 and sentiments around vaccinations, an emerging preference for both in-person and virtual care and demand for more digital capabilities.

COVID-19 Impact on Care

According to this year’s survey results, 62% of respondents missed a scheduled healthcare appointment over the last 12 months, citing various reasons, including COVID-19 (27%). Missed appointments increased 9% compared to last year’s survey findings and varied widely across ethnicity groups, affecting Hispanics the most (85%), followed by Black/African Americans (74%), whites (57%) and Asians (44%).

Once a COVID-19 vaccine becomes widely available, 84% of respondents plan to get it; 3% higher than those who plan to get the annual flu shot this year (81%). When asked where you would feel safest receiving the COVID-19 vaccine, the top selection from respondents was doctor’s office (48%), followed by hospital (33%) and pharmacy (29%). In contrast to DocASAP’s “Telehealth Consumer Experience” survey on July 28th, 26% felt doctor’s offices were the safest facility to enter. Further, more respondents said they would feel safer receiving the vaccine in a grocery store with a walk-in clinic (16%) or retail store with a walk-in clinic (15%) than a drive-thru vaccination site (7%). As states and healthcare leaders develop vaccination distribution plans, understanding patient preference will be critical to ensuring mass immunization.

Accelerated Demand for Timely, Convenient Care

The evolution of alternate care settings, including the dramatic rise in telehealth due to the current pandemic, is accelerating healthcare consumer demand for timely, convenient care. In fact, when asked “what would influence your decision to switch healthcare providers,” the top response was “provider’s location is more convenient” (44%), followed by “provider is available for both telehealth and in-person visits” (40%) and “provider has near-term availability when I need care” (37%).

When asked, “what is the longest time you would prefer to wait between scheduling a routine doctor’s appointment and visiting the doctor,” 85% of respondents indicated no more than two weeks, up 5% from last year’s survey. Broken down by age, the preferred wait time between scheduling a routine doctor’s appointment and visiting the doctor was “0-3 days” for Gen Z (ages 18-23) and Baby Boomers (ages 56+), and “4-7 days” for Millennials (ages 24-39) and Gen X (ages 40-55).

When asked “if you were unable to schedule an appointment with your primary care doctor when you wanted care, which care option would you consider?” the survey found that 87% of respondents would find “another provider,” with 50% selecting “a different provider within the same practice in-person,” followed by “urgent care center” (35%) and “online video visit/telehealth with a different provider” (30%).

The Shift to a Digital-First Mindset

To improve patient outcomes, drive engagement and increase loyalty in the new normal, healthcare providers must adopt a “digital-first” mindset. When asked about specific care settings, the survey found that post-COVID-19, the majority of respondents (44%) would prefer to receive care both in-person and via telehealth.    

When asked “how you prefer to schedule an appointment with a healthcare provider,” most respondents (48%) cited scheduling online compared to over the phone (39%) and in-person (10%). Further, 74% of respondents said that scheduling a healthcare appointment outside of business hours is important. This number was highest among Black/African Americans (91%).

Digital remains king for both pre-appointment and post-appointment communications. When asked, “what is your preferred method for receiving an appointment reminder for a scheduled healthcare visit,” the majority of respondents (56%) selected digital methods (i.e. email or text message), an increase of 4% compared to last year. A deeper dive found that “text message” was selected as the preferred method for receiving an appointment reminder across all ethnicity groups. Digital methods (i.e. email, text message, online portal or mobile app) were also cited as the preferred method for receiving post-appointment communication from a healthcare provider (64%), up six percent compared to last year’s survey.

Additional notable findings:

  • On the heels of a tumultuous year, “not losing healthcare coverage” was the most important healthcare issue for respondents (40%), followed by “reducing healthcare costs” and “pre-existing condition protection” (35%, respectively).
  • Twenty-one percent of respondents cited “access to mental health services” as the most important healthcare issue. This number was highest among Millennials (29%) followed by Gen X (19%), Gen Z (10%) and Baby Boomers (9%).


“Blended care delivery models consisting of both in-person and virtual care are playing a crucial role in improving patient experience and, more importantly, outcomes,” said Puneet Maheshwari, co-founder and CEO of DocASAP. “As we prepare for the next wave of COVID-19 infections, ensuring patient access to the right care provider and care setting at the right time will be critical. This, combined with enhanced healthcare consumer-facing digital capabilities, will streamline the delivery of end-to-end care during the pandemic and beyond.”

To learn more about DocASAP’s second annual “State of Patient Access and Engagement” 2020 survey, visit https://info.docasap.com/en-us/healthcare-consumer-digital-first.

Survey Methodology:

Commissioned by DocASAP, the second annual “State of Patient Access and Engagement” 2020 survey was conducted by OnePoll, a marketing research company specializing in online quantitative research and polling, on October 16, 2020. Feedback was obtained from 1,000 U.S. adults who have used a healthcare provider in the last 12 months.

About DocASAP

DocASAP provides the industry’s most advanced patient access and engagement platform for health systems, health plans and physician groups. DocASAP empowers organizations to navigate patients to the optimal provider and care setting at the right time throughout their access journey, helping improve outcomes, reduce costs and create a better patient experience. Backed and promoted in the market by Aetna, Optum and UnitedHealthcare, DocASAP builds unique payer-provider connections with an eye toward simplified access, increased care compliance and improved population risk management. For more information, visit http://docasap.com or follow on Twitter @DocASAP.

Cellings, the Leggings That Uses Electro Muscle Stimulation Pads to Assist With Muscle Toning and Soreness Recovery Has Surpassed Its Funding Goal


News Image

Despite how easy it is to use EMS technology for muscle care, it has been widely accessible only to professionals in the physical therapy industry.

Tobortec is excited to announce that the company has surpassed its initial Kickstarter funding goal for its newest product, Cellings. Cellings is a pair of leggings that uses electro muscle stimulation (EMS) pads to assist with muscle growth, muscle toning, and soreness recovery.

Despite how easy it is to use EMS technology for muscle care, it has been widely accessible only to professionals in the physical therapy industry. Tobortec sought out to create a lifestyle product that would combine both functional wear and EMS technology that could be enjoyed by anyone at any time. With a team consisting of researchers experienced in creating high-quality activewear and EMS technology, Cellings was created for the general public.

In order to bring this revolutionary product to the market, Tobortec decided to launch a Kickstarter campaign for Cellings in order to bring attention and receive feedback. Now that the campaign is on its way to hit the six-figure mark, the company is hoping that the momentum will allow them to enter major e-commerce markets so that even more people can enjoy the benefits that Cellings has to offer.

During the testing phase, Tobortec discovered that its strategically placed EMS pads on the core muscles, hips, hamstring, and glute areas on the leggings drastically helped with muscle growth, muscle toning, and muscle recovery when combined with moderate amounts of exercise. With 15 different levels of intensity, users can select the setting they are most comfortable with and can slowly work their way up in order to maximize the effects of the EMS pads.

While the technology is one of the key points of Cellings, the design was not compromised during the development process. Cellings is made from premium sweat-wicking materials and the ultra-comfortable fabric allows for maximum movement so that it can withstand any type of movement during physical exercises. Separate sizes and fits for men and women are available. To top it off, the EMS module which can placed on either the right or left side of the hip to target specific areas can be taken off so that Cellings can be washed after each use.

Cellings will be live on Kickstarter until Wednesday, December 2nd, 2020 at 9:00 pm PST. Early-bird reward prices start at $155 and will be exclusive only for Kickstarter backers. Prices are anticipated to go up after the campaign comes to an end. Any editors, journalists, and social media influencers active in the startup scene that are interested in reviewing Cellings are encouraged to submit an inquiry through the Cellings Kickstarter page.

Share article on social media or email:

Leading University and California Independent School District Latest Educational Institutions to Incorporate Apache SafeSpace Solutions’ Proven UV-C Technology


Our whole mission is to get people safely back to work and life.

To support their innovative approaches to keep students, faculty and staff safe, two large, respected educational institutions worked with Apache SafeSpace Solutions to incorporate leading UV-C technology, thermal infrared temperature scanners and other innovative products into their operations.

“Our whole mission is to get people safely back to work and life,” says Mike Knigin, CEO of Apache Industrial Services. “Working with some of the largest and most respected institutions in education to help them get their students and people back safely and to keep them safe is an honor. They both found that in addition to superior technology, the availability and affordability of the custom solutions were game-changers for them.”

Apache Industrial Services, a leader in the industrial services space, has built on its reputation of safety through their carefully designed, advanced technical solutions. In response to the global COVID-19 pandemic, the company quickly pivoted to develop a robust suite of UV-C products to effectively eliminate microbial threats in the air and on surfaces, as well as Mass Temperature Screening Systems that are among the most accurate anywhere. The product suite is known as Apache SafeSpace Solutions.

“There’s a lot of uncertainty out in the world right now, especially within education,” says Knigin. “Our hope is that our SafeSpace products, in conjunction with safety protocols and procedures, provide additional peace of mind to parents, students and teachers.”

Rice University: Rice University partnered with Apache to develop a custom HVAC UV-C system using AIRrowSwift 6000 UV-C panels for their on-campus student isolation wing. In preparation for a returning student body, the university designated the Sid W. Richardson residential college building as an isolation and recovery wing for students infected with COVID-19. Proven UV-C technology mounted on custom-engineered decontamination panels were installed in the building’s air ducts. All airflow in the building is now being treated to eliminate microbial threats such as bacteria, viruses and fungi, creating a safer, cleaner space for staff and recovering students.

“The Apache team was phenomenal from our first conversations to our final walk through to make sure the system was all operating as designed. We are confident that we have created a much safer environment for our staff to work in while housing COVID-positive students,” said Brad Thacker, Senior Operations Manager of Housing and Dining at Rice University. “I cannot thank Mike Knigin and his impressive team enough for all their work and dedication to engineering a solution for our building’s distinctive HVAC system.”

Caruthers Unified School District: Caruthers Unified School District in California partnered with Apache to incorporate a suite of UV-C products that were found to be effective in reducing traces of dangerous microorganisms on hard surfaces. UV-C products, including the Tomahawk 8000, AIRrow 2.0 air purifiers and Tomahawk Ultra-Lights, are being used by staff to routinely treat and decontaminate desks, doorknobs, chairs and whole classrooms.

“The AIRrow 2.0 units are a better size for our classrooms and should be appreciated by everyone for the additional safety they provide,” said a district spokesperson. “While we look forward to when COVID-19 is gone, we know the technology Apache provided will help our staff and students stay safe from airborne and surface contaminates for years to come.”

Apache SafeSpace Solutions continue to be rolled out in school districts, universities, libraries, leading retailers, car dealerships, restaurants, prisons and homes across the United States. To learn more about Apache SafeSpace Solutions, visit http://www.apachesafespacesolutions.com.

Share article on social media or email: